Partner with PGDx from biomarker discovery to CDx
Using our proven technology expedites and streamlines your CDx development process. Our comprehensive panel approach delivers robust insights from a single test, supporting both CDx markers as well as retrospective endpoints.
PGDx offers deep companion diagnostic development expertise and global biopharma partnership experience, with a demonstrated track record of navigating complicated technical and legal frameworks internationally. We leverage this knowledge to power every partnership and support your therapy development and commercialization goals.
Our joint project team and dedicated service coordinators are here to provide best-in-class customer service throughout your project. We provide flexible clinical trial set-up options via in-house testing or through our CRO network. Our team is committed to providing direct support every step of the way as you navigate the regulatory landscape to approval.
Our expertise in trial transfers and established distributed kit model ease the transition from single-site LDTs and enable global patient access. We understand the breadth of molecular diagnostic approaches and platforms, enabling you to bridge efficiently.